Supreme Court: Foreign Judgment Unenforceable in India Without Fair Opportunity to Defend || Supreme Court: High Court Cannot Decide Appeal Pending Before Statutory Authority Due to Delay || Supreme Court: SDO Lacks Authority to Change Land Classification under UP Zamindari Abolition Act || Supreme Court: Man Not Liable For Maintenance if DNA Test Proves He is Not the Child’s Father || SC: Prison Must Not Dilute Rights of Disabled Inmates; Oversight Given to High-Powered Panel || Delhi High Court: Judges Would Have to Recuse if Children as Central Govt Counsel is Treated as Bias || Delhi HC: Fresh Tenders Allowed Despite Existing Contracts; Anticipatory Grievances Not Entertained || Delhi High Court: Judges Cannot Respond Publicly; Criticism Must Be Responsible and Evidence-Based || J&K&L High Court: IO Not Bound By FIR; Can Modify Offences in Final Chargesheet U/S 173 CrPC || Supreme Court: Brief Service Breaks Do Not Bar Ad Hoc Employees From Regularisation

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :